上海首支生物制造产业基金成立，国投先导、道彤投资与奥浦迈共同发起

Core Viewpoint - The establishment of Shanghai's first biomanufacturing industry fund aims to integrate resources from enterprises, universities, and research institutions to promote technological breakthroughs and business growth [1] Group 1 - The fund is initiated by Guotou Xian Dao Fund under Shanghai Guotou Company, in collaboration with Daotong Investment and Aopumai [1] - The fund adopts a "C (industry chain leading enterprises) + VC (professional investment institutions)" dual-driven model [1] - Aopumai is recognized as a leading enterprise in cell culture media, leveraging its industry advantages [1] Group 2 - Daotong Investment brings its expertise in early-stage medical and synthetic biology investments to the fund [1] - The fund aims to foster collaboration among key stakeholders in the biomanufacturing sector [1] - The initiative is expected to drive significant advancements in critical technologies within the industry [1]